Literature DB >> 24082928

Atypical juvenile neuronal ceroid lipofuscinosis: A report of three cases.

Gururaj Setty1, Rashid Saleem, Arif Khan, Nahin Hussain.   

Abstract

The diagnosis of juvenile neuronal ceroid lipofuscinosis (JNCL) is usually based on age of onset, initial clinical symptoms, clinical progression, and pathologic findings. Our cases manifested atypical clinical symptomatology and/or pathologic findings and therefore, represent variant forms of JNCL. Case 1 and 2 presented with slow developmental regression from the age of 4 years and became blind and wheelchair bound at around 8 years. Pathologic finding of lymphocytes showed fingerprint inclusion which was consistent with JNCL. Mutational analysis was positive for CLN5 which usually presents as variant late infantile NCL (LINCL) and more common in Finnish population. Case 3 presented with progressive visual loss from the age of 8 years. Clinical symptomatology and age of onset were similar to that of JNCL but was found to have low palmitoyl protein thioesterase, granular inclusion body, and CLN1 mutation, thus representing milder form of INCL. These three cases demonstrated phenotypic-genotypic variations. Pertinent issues relating diagnostic difficulties, ophthalmologic, neuroradiological, and laboratory aspects are discussed.

Entities:  

Keywords:  CLN1; CLN5; granular inclusion; juvenile neuronal ceroid lipofuscinoses; visual loss

Year:  2013        PMID: 24082928      PMCID: PMC3783717          DOI: 10.4103/1817-1745.117840

Source DB:  PubMed          Journal:  J Pediatr Neurosci        ISSN: 1817-1745


  8 in total

1.  Novel CLN1 mutation in two Italian sibs with late infantile neuronal ceroid lipofuscinosis.

Authors:  Maria Bonsignore; Alessandra Tessa; Gabriella Di Rosa; Fiorella Piemonte; Carlo Dionisi-Vici; Alessandro Simonati; Filippo Calamoneri; Gaetano Tortorella; Filippo M Santorelli
Journal:  Eur J Paediatr Neurol       Date:  2006-06-08       Impact factor: 3.140

2.  Neurological deterioration in late infantile neuronal ceroid lipofuscinosis.

Authors:  S Worgall; M V Kekatpure; L Heier; D Ballon; J P Dyke; D Shungu; X Mao; B Kosofsky; M G Kaplitt; M M Souweidane; D Sondhi; N R Hackett; C Hollmann; R G Crystal
Journal:  Neurology       Date:  2007-08-07       Impact factor: 9.910

3.  Palmitoyl-protein thioesterase deficiency in a novel granular variant of LINCL.

Authors:  K E Wisniewski; F Connell; W Kaczmarski; A Kaczmarski; A Siakotos; C R Becerra; S L Hofmann
Journal:  Pediatr Neurol       Date:  1998-02       Impact factor: 3.372

4.  Studies of atypical JNCL suggest overlapping with other NCL forms.

Authors:  K E Wisniewski; N Zhong; W Kaczmarski; A Kaczmarski; S Sklower-Brooks; W T Brown
Journal:  Pediatr Neurol       Date:  1998-01       Impact factor: 3.372

5.  Visual "release" hallucinations in juvenile neuronal ceroid-lipofuscinosis.

Authors:  D J Lanska; M J Lanska
Journal:  Pediatr Neurol       Date:  1993 Jul-Aug       Impact factor: 3.372

6.  MRI of neuronal ceroid lipofuscinosis. I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis.

Authors:  T Autti; R Raininko; S L Vanhanen; P Santavuori
Journal:  Neuroradiology       Date:  1996-07       Impact factor: 2.804

7.  Experience over 17 years with antioxidant treatment in Spielmeyer-Sjögren disease.

Authors:  P Santavuori; H Heiskala; T Westermarck; K Sainio; R Moren
Journal:  Am J Med Genet Suppl       Date:  1988

8.  [Acute optical hallucinations in the juvenile neuronal ceroid lipofuscinosis (Spielmeyer-Vogt syndrome)].

Authors:  T von Villiez; I Lagenstein; P Koepp
Journal:  Acta Paedopsychiatr       Date:  1981-05
  8 in total
  6 in total

1.  The Neuronal Ceroid Lipofuscinoses-Linked Loss of Function CLN5 and CLN8 Variants Disrupt Normal Lysosomal Function.

Authors:  Shaho Parvin; Maryam Rezazadeh; Hassan Hosseinzadeh; Mohsen Moradi; Shadi Shiva; Jalal Gharesouran
Journal:  Neuromolecular Med       Date:  2019-03-27       Impact factor: 3.843

Review 2.  A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.

Authors:  I Basak; H E Wicky; K O McDonald; J B Xu; J E Palmer; H L Best; S Lefrancois; S Y Lee; L Schoderboeck; S M Hughes
Journal:  Cell Mol Life Sci       Date:  2021-04-01       Impact factor: 9.261

3.  Brain imaging in Kufs disease type B: case reports.

Authors:  Roberto Di Fabio; Claudio Colonnese; Filippo Maria Santorelli; Liliana Pestillo; Francesco Pierelli
Journal:  BMC Neurol       Date:  2015-07-04       Impact factor: 2.474

4.  Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses.

Authors:  Kristiina Uusi-Rauva; Tea Blom; Carina von Schantz-Fant; Tomas Blom; Anu Jalanko; Aija Kyttälä
Journal:  Int J Mol Sci       Date:  2017-05-01       Impact factor: 5.923

5.  Revealing the clinical phenotype of atypical neuronal ceroid lipofuscinosis type 2 disease: Insights from the largest cohort in the world.

Authors:  Charles M Lourenço; Andre Pessoa; Carmen C Mendes; Carolina Rivera-Nieto; Diane Vergara; Mónica Troncoso; Emily Gardner; Francisca Mallorens; Lina Tavera; Luis A Lizcano; Nora Atanacio; Norberto Guelbert; Norma Specola; Nury Mancilla; Carolina F M de Souza; Sara E Mole
Journal:  J Paediatr Child Health       Date:  2020-12-30       Impact factor: 1.954

6.  The c.863A>G (p.Glu288Gly) variant of the CTSD gene is not associated with CLN10 disease.

Authors:  Juan Yang; Xiaoting Ding; Shasha Meng; Jinhua Cai; Weihui Zhou
Journal:  Mol Genet Genomic Med       Date:  2021-07-31       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.